tm logo
GRITSTONE
Live/Registered
REGISTERED

on 23 Nov 2021

Last Applicant/ Owned by

5959 Horton Street, Suite 300

Emeryville

CA

94608

Serial Number

87748380 filed on 09th Jan 2018

Registration Number

6569577 registered on 23rd Nov 2021

in the Principal Register

Correspondent Address

Fidel Nwamu

Fidel Nwamu

7751 Carondelet Ave, Suite 405

Clayton MO 63105

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

GRITSTONE

Providing temporary use of on-line nondownloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer; conducting early evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


healthcare


First Use Date in General

18th Mar 2019

First Use Date in Commerce

18th Mar 2019

Class [042]
Computer & Software Services & Scientific Services


Providing temporary use of on-line nondownloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer; conducting early evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services for others in the field of design, planning, and implementation of clinical trials; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice


First Use Date in General

17th Sep 2016

First Use Date in Commerce

17th Sep 2016

Class [009]
Computer & Software Products & Electrical & Scientific Products


next-generation sequencing (NGS) data processor; bioinformatics data processor; downloadable computer software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry


First Use Date in General

17th Sep 2016

First Use Date in Commerce

17th Sep 2016

Class [005]
Pharmaceutical Products


pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; vaccines; vaccine preparations


First Use Date in General

18th Mar 2019

First Use Date in Commerce

18th Mar 2019

Mark Details


Serial Number

No 87748380

Mark Type

No Service Mark

Attorney Docket Number

No GRITST.001TM

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
26th Dec 2023COUNTERCLAIM OPP. NO. 999999
23rd Nov 2021REGISTERED-PRINCIPAL REGISTER
21st Oct 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21st Oct 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
20th Oct 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
18th Oct 2021STATEMENT OF USE PROCESSING COMPLETE
15th Oct 2021TEAS STATEMENT OF USE RECEIVED
15th Oct 2021USE AMENDMENT FILED
23rd Jun 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
17th Jun 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED